Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2026
Endoscopic Papillectomy May Be a Feasible Treatment Option for Elderly Patients With Ampullary Tumors: A Multicenter Retrospective Study.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kasuga Noriki, Kurita Yusuke, Sekino Yusuke, Nagai Keiki, Fujita Yuji, Hemmi Riko, Imanaga Daiki, Kaneda Manato, Matsumoto Shota, Suzuki Masato, Yagi Shin, Kubota Kensuke, Yoneda Masato
Аннотация
OBJECTIVES: Endoscopic papillectomy (EP) is a minimally invasive treatment for ampullary tumors; however, its safety in elderly patients remains unclear. We aimed to evaluate the feasibility and clinical outcomes of EP in this population.
METHODS: This multicenter retrospective study included 255 patients with ampullary tumors who underwent EP between April 2008 and September 2025 at three collaborating institutions. Patients aged ≥ 75 years were defined as elderly; complication rates and clinical outcomes were compared with the non-elderly group.
RESULTS: The elderly group had a significantly higher Charlson Comorbidity Index (1.0 [0-8] vs. 0 [0-7]; p = 0.028). The elderly group demonstrated significantly lower rates of overall complications (29.0% vs. 48.9%; p = 0.004), delayed bleeding (4.3% vs. 23.1%; p < 0.001), and pancreatitis (11.6% vs. 23.1%; p = 0.041) than the non-elderly group. Serious complications rate (4.3% vs. 4.8%; p = 1.000), median hospital stay (12 [7-73] vs. 13 [4-40] days; p = 0.408) were comparable between groups. Multivariate analysis showed that age ≥ 75 years was independently associated with a reduced risk of delayed bleeding (p = 0.002; odds ratio [OR], 0.14) and pancreatitis (p = 0.029; OR, 0.39).
CONCLUSIONS: EP in patients aged ≥ 75 years was associated with lower complication rates and may be a feasible treatment option.
METHODS: This multicenter retrospective study included 255 patients with ampullary tumors who underwent EP between April 2008 and September 2025 at three collaborating institutions. Patients aged ≥ 75 years were defined as elderly; complication rates and clinical outcomes were compared with the non-elderly group.
RESULTS: The elderly group had a significantly higher Charlson Comorbidity Index (1.0 [0-8] vs. 0 [0-7]; p = 0.028). The elderly group demonstrated significantly lower rates of overall complications (29.0% vs. 48.9%; p = 0.004), delayed bleeding (4.3% vs. 23.1%; p < 0.001), and pancreatitis (11.6% vs. 23.1%; p = 0.041) than the non-elderly group. Serious complications rate (4.3% vs. 4.8%; p = 1.000), median hospital stay (12 [7-73] vs. 13 [4-40] days; p = 0.408) were comparable between groups. Multivariate analysis showed that age ≥ 75 years was independently associated with a reduced risk of delayed bleeding (p = 0.002; odds ratio [OR], 0.14) and pancreatitis (p = 0.029; OR, 0.39).
CONCLUSIONS: EP in patients aged ≥ 75 years was associated with lower complication rates and may be a feasible treatment option.